Abstract
The critical dependence of the Russian pharmaceutical market on imported medicines necessitated the industry’s transition to an import-substituting vector. The priority of replacing imported medicines with domestic ones, the full production cycle of which is located on the Russian territory, was fixed in the Federal Target Program “Pharma-2020”, the implementation of which made it possible to increase the production of domestic medicines significantly. However, there are currently certain problems in the industry, which are advisable to identify using SWOT analysis. The weaknesses of industry development include dependence on imported raw materials, primary pharmaceutical substances, commercialization of some technologies that are strategically important for the development of the industry, and the protracted transition of domestic enterprises to the good manufacturing practice (GMP) standard. The most significant industry challenge is sanctions and macroeconomic instability. Additionally, there are a number of personnel and infrastructure problems. To eliminate adverse factors, the Federal Target Program “Pharma-2030” is being developed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evstratov, A. V. (2018). The main trends and prospects for developing the pharmaceutical market in the Russian Federation. Volgograd State Technical University.
Government of the Russian Federation. (2020). Decree “On peculiarities of circulation of medicines for medical use, which are intended for use in conditions of threat of emergence, emergence, and liquidation of an emergency situation and for organization of medical assistance to persons affected by emergencies, prevention of emergency situations, prevention and treatment of diseases that are dangerous to the environment, and diseases and injuries suffered as a result of adverse chemical, biological, and radiation factors” (April 3, 2020 No. 441). Retrieved from https://www.garant.ru/products/ipo/prime/doc/73750814/ (Accessed 8 November 2022).
Izmaylov, A. M, Evstratov, A. V., & Heidelberg, E. (2022). Big Data applications in the pharmaceutical industry. In S. I. Ashmarina, & V. V. Mantulenko (Eds.), Digital technologies in the new socio-economic reality (pp. 67–72). Springer. https://doi.org/10.1007/978-3-030-83175-2_10.
Ministry of Industry and Trade of the Russian Federation. (2009). Order “On approval of the Strategy for the development of the pharmaceutical industry of the Russian Federation for the period up to 2020” (October 23, 2009 No. 965). Retrieved from https://base.garant.ru/4189282/ (Accessed 8 November 2022).
Narkevich, I. A., & Trofimova, E. O. (2011). New generation of manpower for pharmaceutical industries. Remedium, 6, 68–73. Retrieved from https://cyberleninka.ru/article/n/perspektivy-obespecheniya-farmatsevticheskoy-promyshlennosti-kadrami-novogo-tipa (Accessed 15 October 2022).
Oborin, M. S. (2021). Problems and prospects of import substitution in the pharmaceutical industry. Bulletin of the National Research Institute of the Russian Academy of Sciences, 5(120), 101–110. https://doi.org/10.24412/2227-9407-2021-5-101-110
Portal of state programs of the Russian Federation. (n.d.). Development of pharmaceutical and medical industry. Retrieved from https://programs.gov.ru/Portal/programs/subActionsList?gpId=20&pgpId=24801570-3136-4bd8-94ac-bd9231e06bbb (Accessed 8 November 2022).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dneprovskaya, I.V., Arakelova, I.V., Legenkova, N.M., Danilenko, E.E., Tikhonova, A.L. (2023). The Prospects for the Development of the Domestic Pharmaceutical Industry in the Context of Import Substitution. In: Popkova, E.G., Sergi, B.S. (eds) Anti-Crisis Approach to the Provision of the Environmental Sustainability of Economy. Approaches to Global Sustainability, Markets, and Governance. Springer, Singapore. https://doi.org/10.1007/978-981-99-2198-0_5
Download citation
DOI: https://doi.org/10.1007/978-981-99-2198-0_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-2197-3
Online ISBN: 978-981-99-2198-0
eBook Packages: Business and ManagementBusiness and Management (R0)